Dr. Shashi N. Kapadia, MD

Dr. Kapadia practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Kapadia's NPI, 1578862751, was assigned on March 27, 2011. Dr. Kapadia graduated from Rutgers New Jersey Medical School in 2011. Dr. Kapadia holds New York license 275055.

Dr. Kapadia's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Kapadia's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Kapadia to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kapadia practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kapadia's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kapadia is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Kapadia's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists hiv/aids and pneumonia among the conditions Dr. Kapadia treats.

CMS data shows 87 Medicare services from Dr. Kapadia across 3 procedure codes in 2024, for 59 Medicare patients. Medicare paid $8,478 for them.

CMS counts 59 Medicare patients who saw Dr. Kapadia in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kapadia's median patient age at 57, with 35% women.

In 2024, Dr. Kapadia wrote 142 Medicare Part D claims for 17 patients. 68% of them were for generic drugs. CMS names the drug for 86 of them, across 6 drugs with 11 or more claims each, at $121,532 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kapadia for performance year 2024, reported through an alternative payment model (APM). Dr. Kapadia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Kapadia, published from 2018 to 2025. 2022 was the busiest year, with 13. The most frequent topics are Hepatitis C, Hepacivirus and Substance Abuse, Intravenous. Dr. Kapadia has published most often in J Gen Intern Med. Dr. Kapadia's most frequent co-authors are Kristen M. Marks, MD, David C. Perlman, MD and Christopher J. Gonzalez, MD.

CMS Open Payments shows 2 general payments to Dr. Kapadia from 2 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Shionogi Inc paid the most, $125.

Dr. Kapadia graduated from Rutgers New Jersey Medical School in 2011.

Dr. Kapadia is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.